Correction: Targeting the oxidative microenvironment with a tannic acid-modified manganese dioxide nanozyme loaded with Honokiol nanoplatform to activate sirtuin 3-mediated deacetylation for alleviating cerebral ischemia-reperfusion injury
Xin Yang, Yujing Cheng, Chengyuan Liu, Yuanju Chen, Ying Wang, Zhuang Li, Qiuxia Xiong, Chan Zhang · 2026
Read Correction: Targeting the oxidative microenvironment with a tannic acid-modified manganese dioxide nanozyme loaded with Honokiol nanoplatform to activate sirtuin 3-mediated deacetylation for alleviating cerebral ischemia-reperfusion injury by Xin Yang, Yujing Cheng, Chengyuan Liu, Yuanju Chen, Ying Wang, Zhuang Li, Qiuxia Xiong, Chan Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13322052.txt.
Description
Xin Yang and colleagues issue a 2026 correction to their study of a nanozyme platform for brain injury after restored blood flow. The original article, in Journal of Nanobiotechnology, tested a tannic acid modified manganese dioxide nanozyme carrying honokiol to ease cerebral ischemia-reperfusion injury by activating sirtuin 3 pathways. The correction adds a missing funding note.
The funding section should have stated that Yunnan Beisite Biotechnology took part as a collaborating partner of a blood transfusion department at a Yunnan hospital. The corrected statement also records animal ethics approval, numbered BST-PZ-MICE-20251014-01 in the notice. The original article has been updated, and no results are changed by the correction.
Catalog record
| CREATOR | Xin Yang, Yujing Cheng, Chengyuan Liu, Yuanju Chen, Ying Wang, Zhuang Li, Qiuxia Xiong, Chan Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1274 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |